A sterling opportunity for pharma leaders to deepen expertize, broaden professional horizons and strengthen connections is drawing nearer with every passing day. A whole lot of 1300+ professionals are preparing to discuss the latest trends and sum up latest industry achievements this March.

No better way to start off 2019 than discussing the latest insights from the world of digital pharma. At Digital Pharma Advances Conference, we’ll be doing just that – speaking digital and nothing but digital within the two full days of dynamic discussions are for the insight-avid participants.

How to use digital to cope with consumerization of healthcare? How to further the leap beyond the pill to a holistic value-bringing paradigm? What exactly should personalized customer experience mean in pharma? This is what brings leading enterprises together in Philadelphia this November.

LATAM’s healthcare systems could benefit hugely from what pharma has to offer – but only with value-based collaborations. This is what brings 200+ executives from the world’s leading pharma companies together in Miami. Well-known names in life sciences like Novartis, Teva, Roche, GSK – but also Microsoft and AWS – will discuss the fine details of aligning healthcare transformations in LATAM with doctor-patient-pharma interactions.

When a large event is organized by eyeforpharma, it immediately attains the scale where no heavy promotion is needed. This time, over 700 pharma leaders are expected to participate actively, including Astellas, Novartis, Bayer, Ferring, Teva, and GSK, to name just a few. All of these will share their experience and success cases around the single but broad topic: how to increase the impact pharma is making on patients?